The pressure against pharmacy benefit managers (PBMs ... Express Scripts and Optum Rx) on specialty generic drugs, highlighting substantial price markups by PBMs on medications for cancer ...

Staff’s latest report found that the ‘Big 3 PBMs’—Caremark Rx, LLC (CVS), Express Scripts, Inc. (ESI), and OptumRx ... specialty generic drugs over the study period. PBM-affiliated ...

Pharmacy benefit managers CVS Caremark, OptumRx and Express Scripts inflated costs for specialty generic drugs to treat diseases such as cancer and HIV to the tune of $7.3 billion over six years ...

industry dominance and marking up the prices of specialty drugs. The report specifically looked at the business practices of the Caremark Rx, Express Scripts and OptumRx, which are in turn owned ...

FTC: ‘Big 3’ Pharmacy Benefit Managers Engaged in Price Gouging, PBMs, UnitedHealth OptumRx, CVS Caremark Rx, Express Scripts ...

CVS Caremark, Express Scripts and OptumRx dramatically ... The FTC’s findings—which analyzed 51 specialty generic drugs from 2017 to 2022—showed these pharmacy benefit managers’ (PBMs ...

Drug distributor Cardinal Health on Thursday raised its fiscal 2025 adjusted profit forecast as strong demand for costly specialty medicines and branded drugs drove sales at its pharmaceuticals unit.

The pressure against pharmacy benefit managers (PBMs) continues to build. On Tuesday, the Federal Trade Commission released ...

Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in ...

Opens in a new tab or window The three largest pharmacy benefit managers (PBMs) inflated the price of specialty generic ... Express Scripts, and OptumRx -- "hiked costs for a wide range of ...